Buprenorphine was approved to treat opioid use disorder at the beginning of the century and has shown positive outcomes and reduced overdoses. It is often used on its own to relieve the symptoms of opioid withdrawal but is more commonly combined with Naloxone in a product most widely known as Suboxone.
Buprenorphine and HIV prevention among injecting drug addicts
Change in the role of buprenorphine (and other medicines used in agonist pharmacotherapy of opioid dependence, like methadone) is generally recognized now as an effective treatment for opioid addiction.
Buprenorphine maintenance treatment programs give opportunities for expanded HIV prevention among injecting drug users and a platform for implementing directly observed antiretroviral therapy for people with opioid dependence who also have HIV/AIDS. It works well as a therapy for opportunistic infections such as tuberculosis in such individuals.
Sublingual tablets of buprenorphine
Given the great importance for public health of buprenorphine, sublingual tablets are of lesser interest for abuse and recreation, as they lack the physiological effect as immediate as injections have.
There are large-scale psychosocially assisted pharmacological treatment programs for people dependent on opioids with buprenorphine. To explore this approach of exempting sublingual tablets from specific control measures to increase the ease of access for medicinal purposes.
International health organizations recommend that countries could consider exempting combination sublingual tablets with buprenorphine and naloxone from specific control measures since buprenorphine is also difficult to extract from these pills.
Though it is still considerable and even increasing abuse of buprenorphine by injection. However, as buprenorphine was included in the list of essential drugs, and its great usefulness in inpatient treatment was thus confirmed, it meets the criteria for Schedule III of the Convention on Psychotropic Substances (1971) and should therefore remain, as it already is, under this Schedule. The risk of abuse of sublingual tablets is relatively low.
At La Jolla Recovery, we want to provide optional medication-assisted treatment services, including buprenorphine and suboxone, to more readily attend the detox and withdrawal process of opiates such as heroin, fentanyl, and other abused prescriptions. If concomitant opiates were done with alcohol or stimulants like cocaine, we would be providing a program specific to its detoxification with clinical supervision. If mental health disorders also need attention, we provide dual-diagnosis therapy. We believe by attending the mind with evidence-based research, we can prolong sobriety and provide support in transitioning. At La Jolla Recovery buprenorphine rehab, we believe that a family system approach is more effective than treating the individual. Learn more about our family program to support medication-assisted management. Other medication-assisted treatment optional treatments include Vivitrol and different, more modern approaches instead of detoxing from methadone.
If you are coming from out of state and requiring attention on intake and coordination, please let us know. Whether from New York, Texas, Arizona, or Florida, we want to make San Diego your new home. Not into twelve steps or AA? No worries, we meet you where you are at and are here to provide a tailored program for your medication-assisted treatment.